A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer. (Q53984577)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article
Language Label Description Also known as
English
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer.
scientific article

    Statements

    title
    A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17020981
    retrieved
    23 May 2018
    reference URL
    http://europepmc.org/abstract/MED/17020981
    author name string

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q53984577&oldid=2143272732"